Search Within

Michael John Mauro

Formats
  1. Meeting Abstract (188)
  2. Journal Article (67)
  3. Review (8)
  4. Correspondence (4)
  5. Research Letter (3)
  6. Book Section (2)
  7. Editorial (2)
  8. Guidelines (2)
Groups
  1. Adult Leukemia (276)
  2. Center for Hematologic Malignancies (276)
  3. Department of Medicine (276)
  4. Hematologic Malignancies, Division of (276)
  5. Biostatistics Service (10)
  6. Epidemiology and Biostatistics (10)

More Groups

People
  1. Raajit Rampal (12)
  2. Ellin Berman (8)
  3. Eytan Stein (8)
  4. Martin Tallman (7)
  5. Amber King (6)
  6. Andriy Derkach (6)

More People

Years
  1. 2025 (7)
  2. 2024 (17)
  3. 2023 (26)
  4. 2022 (33)
  5. 2021 (21)
  6. 2020 (26)

More Years

Publications
  1. Blood (97)
  2. Clinical Lymphoma, Myeloma and Leukemia (44)
  3. Journal of Clinical Oncology (22)
  4. Haematologica (21)
  5. Leukemia (12)
  6. American Journal of Hematology (8)

More Publications

Publishers
  1. American Society of Hematology (101)
  2. Elsevier Inc. (47)
  3. American Society of Clinical Oncology (22)
  4. Ferrata Storti Foundation (21)
  5. Nature Publishing Group (13)
  6. John Wiley & Sons (8)

More Publishers

Results (276)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Four-year minimum follow-up of ongoing patients (pts) with chronic-phase chronic myeloid leukemia (CP-CML) in a phase 1 trial of ponatinib (PON)
    Meeting Abstract

    Talpaz, M.; Cortes, J. E.; Kantarjian, H. M.; Shah, N. P.; Bixby, D. L.; Flinn, I.; O'Hare, T. J.; Hu, S. M.; Rivera, V. M.; Clackson, T. P.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Elevated blood pressure (BP) and adverse events (AEs) of hypertension (HTN) in ponatinib (PON) leukemia trials
    Meeting Abstract

    Khoury, H. J.; Baccarani, M.; Guilhot, F.; Hochhaus, A.; Hughes, T. P.; Lipton, J. H.; Lustgarten, S.; Yanase, K.; Conlan, M. G.; Cortes, J. E.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Treatment-adherence beliefs and behaviors in patients with chronic myeloid leukemia (CML)
    Meeting Abstract

    Buzaglo, J. S.; Karten, C.; Miller, M. F.; Greer, J. A.; Weiss, E. S.; Mauro, M. J.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Unique cutaneous reaction to second- and third-generation tyrosine kinase inhibitors for chronic myeloid leukemia
    Meeting Abstract

    Patel, A.; Solomon, A.; Mauro, M.; Ehst, B. D.
    Journal of Investigative Dermatology (2015)

    Fulltext@MSK | Save
  • Cardiovascular and pulmonary adverse events in patients treated with BCR-ABL inhibitors: Data from the FDA Adverse Event Reporting System
    Journal Article

    Cortes, J.; Mauro, M.; Steegmann, J. L.; Saglio, G.; Malhotra, R.; Ukropec, J. A.; Wallis, N. T.
    American Journal of Hematology (2015)

    Fulltext@MSK | Save
  • Chronic myeloid leukemia and pregnancy
    Book Section

    Mauro, M. J.
    In Abutalib, S. A.; Markman, M. (Eds.) Cancer Consult: Expertise for Clinical Practice (2014)

    Fulltext@MSK | Save
  • Blast crisis of chronic myeloid leukemia
    Book Section

    Mauro, M. J.
    In Abutalib, S. A.; Markman, M. (Eds.) Cancer Consult: Expertise for Clinical Practice (2014)

    Fulltext@MSK | Save
  • Selecting treatment options for TKI-resistant chronic myeloid leukemia
    Journal Article

    Mauro, M. J.
    Clinical Advances in Hematology & Oncology (2014)

    Fulltext@MSK | Save
  • An open-label, phase 1b, dose-escalation study (CA180-373) of dasalinib plus itivollimab, an investigational anti-programmed cell death 1 (PD-1) antibody, in patients (pts) with previously treated chronic myeloid leukemia (CML)
    Meeting Abstract

    Porkka, K.; Mauro, M. J.; Lipton, J. H.; Mahon, F. X.; Strauss, L. C.; Geese, W. J.; Kroog, G. S.; Mustjokl, S.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Treatment-free remission (TER) following nilotinib (NIL) in patients (pis) with chronic myeloid leukemia in chronic phase (CML-CP): ENESTfreedom, ENESTop, ENESTgoal, and ENESTpath
    Meeting Abstract

    Mahon, F. X.; Baccarani, M.; Mauro, M. J.; Hughes, T. P.; Sagilo, G.; Savona, M.; Szczudlo, T. K.; Menssen, H. D.; Keir, C. H.; Walasok, C.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save